Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatic Disease Does Not Preclude Pregnancy

Ruth Jessen Hickman, MD  |  Issue: November 2017  |  November 9, 2017

Dr. Sammaritano

Dr. Sammaritano

Another expert in this area is Lisa Sammaritano, MD. Dr. Sammaritano is associate professor of clinical medicine in the Division of Rheumatology, Hospital for Special Surgery at Weill Cornell Medicine in New York. Dr. Sammaritano believes that time is the major factor preventing rheumatologists getting involved in preconception and contraceptive planning, but that rheumatologists’ general lack of familiarity with the topic is another barrier.

The Rheumatologist’s Role

Clearly, rheumatologists need to play some role in making sure their patients receive contraception and preconception education. This does not necessarily have to entail prescribing contraceptives, though it may in some cases. Dr. Chakravarty opts not to prescribe contraception in her practice. However, she has an extended conversation about it with new patients, and she brings it up as part of her routine care questions at regular visits.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“One reason I don’t prescribe contraception is because women with autoimmune diseases, particularly lupus, have a higher incidence of HPV,” she explains. “My thinking is that women with autoimmune diseases or who are immunosuppressed cannot clear the virus as easily as healthy people. I make them go to a gynecologist because I want to make sure they have a pap smear and all that reproductive healthcare.” She commonly refers to several gynecologists in the community with whom she has worked with in the past. “Just like I make sure to refer my patients on hydroxychloroquine to an eye doctor for their retinal screening, I make sure they are set up with a gynecologist.”

Dr. Birru Talabi does provide basic contraception to her patients when needed, although there are certain procedures, like IUD insertions, that she refers to an obstetrician/gynecologist. “The point is, we have to be aware that other providers are not necessarily providing contraceptive services. If we are not comfortable managing that contraception piece, then I think it’s important to develop partnerships with women’s health providers in the community, on whom we can rely and have back-and-forth conversations about patients, to ultimately make sure that patients are getting appropriate contraceptive care.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

There is a need for more consistency of care in this area. In a survey of women with lupus, rheumatoid arthritis or inflammatory bowel disease, 40% of U.S. patients reported that they received inconsistent information from different healthcare professionals.9

Dr. Sammaritano recommends, “Until we are all better educated in this area, and/or guidelines are available that will be read by a wide range of specialists, the best way to ensure good care is physician contact. Call or email the OB-GYN with your thoughts and questions.”

Educate & Listen to Patients

In providing better contraceptive coverage, patient education is key. Patients should understand that in most cases pregnancy will be an option for them should they desire it. However, patients must also understand that to have the lowest possible risks for mother and baby, they should work closely with their rheumatologist to plan their pregnancy. Patients must understand that well-controlled disease leads to lower risk. They also need to know that although some medications are not safe to take during pregnancy, others remain essential.

Page: 1 2 3 4 5 6 7 8 9 | Single Page
Share: 

Filed under:Conditions Tagged with:Autoimmune diseasecontraceptivecounselingEducationInflammatory MyopathiesLupusoutcomepatient carepregnancyRheumatic DiseaseRheumatoid arthritisrheumatologistriskSystemic sclerosisVasculitisWomen

Related Articles

    A Better Family Plan

    October 1, 2007

    How to minimize the risks of pregnancy for women with SLE

    Improved Family Planning Counseling Needed

    May 18, 2018

    In the U.S. today, approximately 45% of pregnancies are unintended or unplanned.1 Although this rate is considerably lower than in the past, women with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) or inflammatory myopathies tend to have better pregnancy outcomes if their disease is well controlled when they conceive. In addition, women taking certain medications…

    Rheumatologists Should Discuss with Patients Use of Immunomodulatory Agents During Pregnancy

    November 16, 2016

    The decision to continue or discontinue immunomodulatory medications during pregnancy is a difficult one for both patients and physicians. On the one hand, when left untreated, rheumatic conditions can cause harm to an unborn child, as well as to the pregnant mother. On the other hand, medications can be harmful to a developing fetus. In…

    Baby on Board: The Rheumatologist’s Role in Family Planning for Patients with Lupus

    January 2, 2020

    For patients with lupus, family planning discussions are vital to achieving positive pregnancy outcomes & maintaining overall health…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences